In:
Epilepsia, Wiley, Vol. 58, No. 11 ( 2017-11), p. 1920-1930
Abstract:
To validate a brief and reliable epilepsy‐specific, health‐related quality of life ( HRQOL ) measure in children with various seizure types, treatments, and demographic characteristics. Methods This national validation study was conducted across five epilepsy centers in the United States. Youth 5–18 years and caregivers of youth 2–18 years diagnosed with epilepsy completed the Peds QL Epilepsy Module and additional questionnaires to establish reliability and validity of the epilepsy‐specific HRQOL instrument. Demographic and medical data were collected through chart reviews. Factor analysis was conducted, and internal consistency (Cronbach's alphas), test–retest reliability, and construct validity were assessed. Results Questionnaires were analyzed from 430 children with epilepsy (M age = 9.9 years; range 2–18 years; 46% female; 62% white: non‐Hispanic; 76% monotherapy, 54% active seizures) and their caregivers. The final Peds QL Epilepsy Module is a 29‐item measure with five subscales (i.e., Impact, Cognitive, Sleep, Executive Functioning, and Mood/Behavior) with parallel child and caregiver reports. Internal consistency coefficients ranged from 0.70–0.94. Construct validity and convergence was demonstrated in several ways, including strong relationships with seizure outcomes, antiepileptic drug ( AED ) side effects, and well‐established measures of executive, cognitive, and emotional/behavioral functioning. Significance The Peds QL Epilepsy Module is a reliable measure of HRQOL with strong evidence of its validity across the epilepsy spectrum in both clinical and research settings.
Type of Medium:
Online Resource
ISSN:
0013-9580
,
1528-1167
DOI:
10.1111/epi.2017.58.issue-11
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
2002194-X
Permalink